GlassScriptPhysician profile
Andrew Stephen Wilson
NPI 1194229336
$7,242.48
in general payments reported to CMS, 2019-2025
17 companies · $3,388 in 2025
The $3,388 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.20 · 2022: $375 · 2023: $513 · 2024: $2,946 · 2025: $3,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,310 · Travel and Lodging: $2,535 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,310.43 |
| Travel and Lodging | $2,535.47 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,500.13 | 2022-2025 | Corevalve Evolut R |
| Abbott Laboratories | $1,375.53 | 2023-2025 | Triclip, Dragonfly Opstar, Ultreon |
| Stryker Corporation | $805.92 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt |
| Edwards Lifesciences Corporation | $801.79 | 2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $755.20 | 2024 | |
| Abiomed | $526.20 | 2023-2024 | Impella |
| Shockwave Medical, INC | $403.85 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $190.58 | 2025 | Gore Cardioform Septal Occluder |
| Cardiva Medical, INC. | $156.70 | 2024 | Optowire |
| Janssen Pharmaceuticals, INC | $153.41 | 2022 | |
| Heartflow, INC. | $144.93 | 2023 | Ffrct |
| Philips North America LLC | $122.34 | 2025 | Labosys |
| Penumbra, INC. | $94.30 | 2025 | Indigo System |
| Lantheus Medical Imaging, INC. | $92.14 | 2022 | |
| Merck Sharp & Dohme LLC | $78.48 | 2023 | Verquvo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.78 | 2022-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $20.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.